Primary Site >> Colorectal Cancer

Gene >> PRTN3

  • 1987
  • 1988
  • 1989
  • 1990
  • 1991
  • 1992
  • 1993
  • 1996
  • 1997
  • 1998
  • 1999
  • 2003
  • 2004
  • 2008
  • 2009
  • 2012
  • 2015
  • 2018
Ref: [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
PMID: 3619460
Ref: Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.
PMID: 3349460
Ref: Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
PMID: 2759735
Ref: Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
PMID: 2297729
Ref: The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma.
PMID: 1892769
Ref: Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
PMID: 1394228
Ref: Localization by whole-body autoradiography of intact and fragmented radiolabeled antibodies in a metastatic human colonic cancer model.
PMID: 1577618
Ref: Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen.
PMID: 7683969
Ref: Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
PMID: 8620497
Ref: Pilot study of enhancement of cisplatin activity by high dose cytarabine in advanced gastric and colorectal (G3/G4) cancer.
PMID: 8931744
Ref: Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.
PMID: 9189130
Ref: [Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
PMID: 9703838
Ref: Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice.
PMID: 10341884
Ref: Stereotactic radiosurgery for brain metastases using a linac system: evaluation of initial local response by imaging.
PMID: 10510905
Ref: Natural T cell immunity against cancer.
PMID: 14555498
Ref: (131)I-NP-4 anti-CEA monoclonal antibody
PMID: 20641780
Ref: (99m)Tc-Arcitumomab
PMID: 20641871
Ref: Radioiodinated anti-CEA monoclonal antibody NP-4 F(ab )2 fragment
PMID: 20641898
Ref: Evaluation of three different CT simulation and planning procedures for the preoperative irradiation of operable rectal cancer.
PMID: 18453024
Ref: A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
PMID: 19147770
Ref: Antiangiogenic tumor therapy by DNA vaccine inducing aquaporin-1-specific CTL based on ubiquitin-proteasome system in mice.
PMID: 22802414
Ref: Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
PMID: 24832153
Ref: The Important Role of the Nuclearity, Rigidity, and Solubility of Phosphane Ligands in the Biological Activity of Gold(I) Complexes.
PMID: 30063270